Annual Reviews, Annual Review of Neuroscience, 1(26), p. 411-440, 2003
DOI: 10.1146/annurev.neuro.26.043002.094946
Full text: Download
▪ Abstract Axon growth inhibitors associated with myelin and the glial scar contribute to the failure of axon regeneration in the injured adult mammalian central nervous system (CNS). A number of these inhibitors, their receptors, and signaling pathways have been identified. These inhibitors can now be neutralized by a variety of approaches that point to the possibility of developing new therapeutic strategies to stimulate regeneration after spinal cord injury.